These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25179083)

  • 1. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.
    Alexandrou AJ; Milnes JT; Sun SZ; Fermini B; Kim SC; Jenkinson S; Leishman DJ; Witchel HJ; Hancox JC; Leaney JL
    J Physiol Pharmacol; 2014 Aug; 65(4):511-23. PubMed ID: 25179083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
    Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
    Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
    Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
    Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.
    Ridley JM; Milnes JT; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2004 Dec; 325(3):883-91. PubMed ID: 15541373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local anesthetic interaction with human ether-a-go-go-related gene (HERG) channels: role of aromatic amino acids Y652 and F656.
    Siebrands CC; Schmitt N; Friederich P
    Anesthesiology; 2005 Jul; 103(1):102-12. PubMed ID: 15983462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
    Jehle J; Ficker E; Wan X; Deschenes I; Kisselbach J; Wiedmann F; Staudacher I; Schmidt C; Schweizer PA; Becker R; Katus HA; Thomas D
    Br J Pharmacol; 2013 Mar; 168(5):1215-29. PubMed ID: 23061993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
    Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
    J Pharmacol Toxicol Methods; 2010; 61(2):178-91. PubMed ID: 20172036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT2 antagonist ketanserin is an open channel blocker of human cardiac ether-à-go-go-related gene (hERG) potassium channels.
    Tang Q; Li ZQ; Li W; Guo J; Sun HY; Zhang XH; Lau CP; Tse HF; Zhang S; Li GR
    Br J Pharmacol; 2008 Oct; 155(3):365-73. PubMed ID: 18574455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of HERG human K+ channels by the antidepressant drug paroxetine.
    Lee SH; Sung MJ; Lee HM; Chu D; Hahn SJ; Jo SH; Choe H; Choi BH
    Biol Pharm Bull; 2014; 37(9):1495-504. PubMed ID: 25177033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine.
    Sánchez-Chapula JA; Navarro-Polanco RA; Sanguinetti MC
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):484-91. PubMed ID: 15558243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements of human ether-a-go-go-related gene channels for block by bupivacaine.
    Siebrands CC; Friederich P
    Anesthesiology; 2007 Mar; 106(3):523-31. PubMed ID: 17325511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of the human ether-à-go-go-related gene channel by imatinib mesylate.
    Dong Q; Fu XX; Du LL; Zhao N; Xia CK; Yu KW; Cheng LX; Du YM
    Biol Pharm Bull; 2013; 36(2):268-75. PubMed ID: 23196655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hERG K+ channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656.
    Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
    Biochem Biophys Res Commun; 2006 Dec; 351(1):273-80. PubMed ID: 17056009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Determinants for the High-Affinity Blockade of Human Ether-à-go-go-Related Gene K + Channel by Tolterodine.
    Wang N; Yang Y; Wen J; Fan XR; Li J; Xiong B; Zhang J; Zeng B; Shen JW; Chen GL
    J Cardiovasc Pharmacol; 2022 Nov; 80(5):679-689. PubMed ID: 35881423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652.
    Jo SH; Hong HK; Chong SH; Won KH; Jung SJ; Choe H
    Eur J Pharmacol; 2008 Sep; 592(1-3):19-25. PubMed ID: 18634780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of midazolam on hERG K+ channel].
    Han SN; Wang P; Zhang W; Zhang LR
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Mar; 31(2):143-7. PubMed ID: 26248421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.
    Park SJ; Kim KS; Kim EJ
    J Appl Toxicol; 2008 Mar; 28(2):104-11. PubMed ID: 17516459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
    Ridley JM; Milnes JT; Hancox JC; Witchel HJ
    J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.
    Melgari D; Brack KE; Zhang C; Zhang Y; El Harchi A; Mitcheson JS; Dempsey CE; Ng GA; Hancox JC
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25911606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the human ether-a-go-go-related gene potassium channel by ketamine.
    Zhang P; Xing J; Luo A; Feng J; Liu Z; Gao C; Ma J
    J Pharm Pharmacol; 2013 Sep; 65(9):1321-8. PubMed ID: 23927470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.